Western Pacific Region Index Medicus

Effectiveness of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people with HIV with historical drug resistance mutations.

Author: Ziwei CHANG ¹ ; Hongyan ZHU ¹ ; Yiting ZHANG ¹ ; Yaling CHEN ¹ ; Jiahui LI ¹ ; Jiamin QIN ² ; Yueping ZHU ³ ; Hongxia WEI ¹ ; Yongfeng YANG ¹ ; Meiyin ZOU ⁴ ; Feng QIAN ³ ; Zhiliang HU ¹
Author Information

1. Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210003, China.
2. Clinical Research Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210003, China.
3. Department of Infectious Diseases, The Affiliated Infectious Diseases Hospital, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215007, China.
4. Department of Infectious Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu 226006, China.
Publication Type:Journal Article
From: Chinese Medical Journal 2024;137(22):2758-2760
CountryChina
Language:English